CS196360B2 - Process for preparing derivatives of phenylpiperazine - Google Patents

Process for preparing derivatives of phenylpiperazine Download PDF

Info

Publication number
CS196360B2
CS196360B2 CS772668A CS266877A CS196360B2 CS 196360 B2 CS196360 B2 CS 196360B2 CS 772668 A CS772668 A CS 772668A CS 266877 A CS266877 A CS 266877A CS 196360 B2 CS196360 B2 CS 196360B2
Authority
CS
Czechoslovakia
Prior art keywords
piperazine
ylmethyl
formula
alkyl
phenyl
Prior art date
Application number
CS772668A
Other languages
Czech (cs)
English (en)
Inventor
John P Verge
William B Jamieson
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of CS196360B2 publication Critical patent/CS196360B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CS772668A 1976-04-23 1977-04-21 Process for preparing derivatives of phenylpiperazine CS196360B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
CS196360B2 true CS196360B2 (en) 1980-03-31

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
CS772668A CS196360B2 (en) 1976-04-23 1977-04-21 Process for preparing derivatives of phenylpiperazine

Country Status (34)

Country Link
JP (1) JPS52151183A (xx)
AR (2) AR222003A1 (xx)
AT (1) AT355579B (xx)
AU (1) AU514822B2 (xx)
BE (1) BE853899A (xx)
BG (2) BG27746A3 (xx)
CA (1) CA1087617A (xx)
CH (2) CH633009A5 (xx)
CS (1) CS196360B2 (xx)
DD (1) DD129790A5 (xx)
DE (1) DE2717415A1 (xx)
DK (1) DK176177A (xx)
ES (2) ES457988A1 (xx)
FI (1) FI63937C (xx)
FR (1) FR2348925A1 (xx)
GB (1) GB1575904A (xx)
GR (1) GR64084B (xx)
HU (1) HU176820B (xx)
IE (1) IE44730B1 (xx)
IL (1) IL51787A (xx)
LU (1) LU77170A1 (xx)
MX (1) MX4596E (xx)
NL (1) NL7704456A (xx)
NO (1) NO146710C (xx)
NZ (1) NZ183715A (xx)
OA (1) OA05643A (xx)
PH (1) PH14124A (xx)
PL (1) PL117466B1 (xx)
PT (1) PT66452B (xx)
RO (1) RO72831A (xx)
SE (1) SE7704536L (xx)
SU (2) SU664564A3 (xx)
YU (1) YU104477A (xx)
ZA (1) ZA771849B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
KR970701705A (ko) * 1994-03-11 1997-04-12 오노다 마사요시 5-HT₃ 수용체 효능제, 신규한 티아졸 유도체 및 이의 중간체(5-HT₃receptor agonist, novel thiazole derivative, and intermediate therefor)
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
ES2462240T3 (es) * 2006-02-28 2014-05-22 Dart Neuroscience (Cayman) Ltd Piperazinas terapéuticas como inhibidores de PDE4

Also Published As

Publication number Publication date
MX4596E (es) 1982-06-25
HU176820B (en) 1981-05-28
PL197550A1 (pl) 1979-05-21
PL117466B1 (en) 1981-08-31
CH625802A5 (en) 1981-10-15
IL51787A0 (en) 1977-05-31
LU77170A1 (xx) 1979-01-18
CA1087617A (en) 1980-10-14
JPS52151183A (en) 1977-12-15
BG28055A3 (en) 1980-02-25
NO146710B (no) 1982-08-16
RO72831A (ro) 1983-08-03
PH14124A (en) 1981-02-26
ATA285177A (de) 1979-08-15
BE853899A (fr) 1977-10-24
AR222003A1 (es) 1981-04-15
CH633009A5 (en) 1982-11-15
GR64084B (en) 1980-01-21
AU514822B2 (en) 1981-02-26
NO771398L (no) 1977-10-25
NO146710C (no) 1982-11-24
FI771287A (xx) 1977-10-24
FR2348925A1 (fr) 1977-11-18
ES467948A1 (es) 1978-11-01
FR2348925B1 (xx) 1980-04-11
DE2717415A1 (de) 1977-11-10
RO72831B (ro) 1983-07-30
ZA771849B (en) 1978-11-29
OA05643A (fr) 1981-04-30
YU104477A (en) 1983-01-21
IE44730L (en) 1977-10-23
DK176177A (da) 1977-10-24
DD129790A5 (de) 1978-02-08
AR222635A1 (es) 1981-06-15
SU727146A3 (ru) 1980-04-05
NL7704456A (nl) 1977-10-25
AT355579B (de) 1980-03-10
FI63937C (fi) 1983-09-12
SE7704536L (sv) 1977-10-24
NZ183715A (en) 1980-04-28
FI63937B (fi) 1983-05-31
ES457988A1 (es) 1978-07-16
AU2438677A (en) 1978-10-26
BG27746A3 (en) 1979-12-12
SU664564A3 (ru) 1979-05-25
GB1575904A (en) 1980-10-01
PT66452A (en) 1977-05-01
PT66452B (en) 1979-03-09
IL51787A (en) 1980-02-29
IE44730B1 (en) 1982-03-10

Similar Documents

Publication Publication Date Title
EP0149884B1 (en) 5-pyridyl-1,3-thiazole derivatives, their production and use
AU2009209885B2 (en) Thiazole derivative and use thereof as VAP-1 inhibitor
EP1248612B1 (en) Novel compounds and compositions as protease inhibitors
LV11181B (en) Nitrogen containing heterocyclic compounds in racemic form or in the form of individual enantiomers thereof
US4560690A (en) 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
JPS5916889A (ja) 2↓−(4↓−ピリジル)↓−チアゾ−ル誘導体
JP2001509166A (ja) 糖尿病および肥満の治療のためのβ▲下3▼作動薬としてのチアゾールベンゼンスルホンアミド
SK286753B6 (sk) Deriváty N-(arylsulfonyl)-beta-aminokyseliny obsahujúce aminometylovú skupinu, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie
JP2758077B2 (ja) 複素環式誘導体、その製造方法、ならびに治療的用途
CZ20033250A3 (en) Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular and related diseases
JPH0251425B2 (xx)
JPH0656809A (ja) チアゾールの分枝状アルキルアミノ誘導体、製造方法および医薬組成物
JP2008539186A (ja) 尿素誘導体、その製造方法、およびその使用
AU782993B2 (en) 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
FR2714059A1 (fr) Dérivés amino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
US4123529A (en) Phenylpiperazine derivatives
US5432179A (en) Piperazine derivatives and pharmaceuticals containing the same
CS196360B2 (en) Process for preparing derivatives of phenylpiperazine
US4935424A (en) 4 or 5-(substituted piperazinylalkyl)-2-aminothiazoles as antipsychotic agents
US5001140A (en) Cycloalkylthiazoles
KR810000758B1 (ko) 페닐 피페라진 유도체의 제조방법
JPH08301841A (ja) スクアレン・エポキシダーゼ活性阻害剤
JPH0261954B2 (xx)
HU190669B (en) Process for preparing 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and -1,1-dioxides
US5041440A (en) Dithiolane derivatives